Selective small‐molecule inhibitors of glycogen synthase kinase‐3 activity protect primary neurones from death
- 1 April 2001
- journal article
- research article
- Published by Wiley in Journal of Neurochemistry
- Vol. 77 (1), 94-102
- https://doi.org/10.1046/j.1471-4159.2001.00251.x
Abstract
No abstract availableKeywords
This publication has 45 references indexed in Scilit:
- Specificity and mechanism of action of some commonly used protein kinase inhibitorsBiochemical Journal, 2000
- Spatially and Functionally Distinct Roles of the PI3-K Effector Pathway during NGF Signaling in Sympathetic NeuronsNeuron, 2000
- A GSK3‐binding peptide from FRAT1 selectively inhibits the GSK3‐catalysed phosphorylation of Axin and β‐cateninFEBS Letters, 1999
- τ is phosphorylated by GSK‐3 at several sites found in Alzheimer disease and its biological activity markedly inhibited only after it is prephosphorylated by A‐kinaseFEBS Letters, 1998
- Downregulation of β-catenin by human Axin and its association with the APC tumor suppressor, β-catenin and GSK3βCurrent Biology, 1998
- Interleukin-3-Induced Phosphorylation of BAD Through the Protein Kinase AktScience, 1997
- Lithium inhibits glycogen synthase kinase-3 activity and mimics Wingless signalling in intact cellsCurrent Biology, 1996
- Glycogen synthase kinase-3β phosphorylates tau protein at multiple sites in intact cellsNeuroscience Letters, 1995
- An automated colorimetric microassay for neuronotrophic factorsDevelopmental Brain Research, 1986
- Observations on rat cerebellar cells in vitro: influence of substratum, potassium concentration and relationship between neurones and astrocytesDevelopmental Brain Research, 1983